期刊文献+

家族性帕金森病患者parkin基因缺失突变的初步研究(英文) 被引量:1

Mutations in parkin gene in patients with familial Parkinson's disease
下载PDF
导出
摘要 目的:探讨中国家族性帕金森病(parkinson'sdisease,PD)患者parkin基因第3~7外显子是否存在缺失突变,及其与该病临床特点的关系。方法:采集6例无血缘相关的家族性PD患者外周血液,提取DNA,通过PCR扩增、琼脂糖凝胶电泳鉴定parkin基因第3~7外显子缺失突变,并结合临床资料分析。结果:6例无血缘相关的家族性PD患者中,发现1例有第5外显子缺失,其遗传模式呈常染色体隐性遗传,起病年龄60岁,临床表现为震颤、僵直和运动迟缓,但无异动症。第3,4,6,7外显子未发现缺失突变。结论:中国家族性PD患者中存在parkin基因第5外显子缺失突变改变。 AIM:To investigate mutations of exon 3-7 of parkin gene in Chinese patients with familial Parkinson's disease(PD) and the clinical characteristics of familial PD. METHODS:Peripheral blood samples were collected from six PD patients who were genetically unrelated with others to extract DNA.Mutation analysis of the exon 3-7 in DNA obtained from peripheral blood was carried out using gradient gel electrophoresis of polymerase chain reaction(PCR) amplification. RESULTS:One patient was found deletion of exon 5 while none was found mutation of exon 3,4,6,and 7.In the patient with exon 5 deletion,PD was inherited as autosomal dominant.Onset of the disease was at 60 years of age.Clinical presentations included tremor, rigidity and hypokinesis,but no chorea. CONCLUSION:Exon 5 deletion has been found in Chinese patients with familial PD.
出处 《中国临床康复》 CSCD 2004年第1期182-183,共2页 Chinese Journal of Clinical Rehabilitation
基金 湖南省科委基金(1013-1)~~
  • 相关文献

参考文献1

共引文献9

同被引文献12

  • 1Lee WH, Bookstein R, Hong F, et al. Human retinoblastoma susceptibility gene:cloning, identification and sequence. Science 1987;235(4794): 1394-9.
  • 2Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68(4): 820-3.
  • 3Mills MD, Windle JJ, Albert DM. Retinoblatoma in transgenic mice: models of hereditary retinoblastoma. Surv Ophthalmol 1999; 43(6): 508-18.
  • 4Wistuba Ⅱ, Tang M, Maitra A, et al. Genome-wide allelotyping analysis reveals multiple sites of alletic loss in gallbladder carcinoma. Cancer Res 2001; 61 (9):3795-800.
  • 5Cavenee WK, Koufos A, Hansen MF. Recessive mutant genes predisposing to human cancer. Mutat Res 1986; 168 (1):3-14.
  • 6Zhu X, Dunn JM, Goddard AD, et al. Meehanism of loss of heterozygosity in retinoblastoma. Cytogenet Cell Genet 1992; 59(4): 248-52.
  • 7Munier FL, Thonney F, Bamlmer A, et al. Prognostic factors associated with loss of heterozygosity at the RB1 locus in retinoblastoma. Ophthalmic genetics 1997;18(1):7-12.
  • 8Lavanchy L, Munier FL, Cousin P, et al. Molecular characterization of the deletion in retinoblastoma patients with 13q14 cytogenetic anomalies. Ophthalmic Genetics 2001; 22(1): 1-10.
  • 9Chiu LL, Lai PS, Low PS, et al. Molecular Studies of Loss of Heterozygosity in Retinoblastoma. Ann Acad Med Singapore 1997; 26(3): 315-9.
  • 10Kato MV, Ishizaki K, Ejima Y, et al. Loss of heterozygosity on chromosome 13 and itsassociation with delayed growth of retinoblastma. Int J Cancer 1993; 54(6):922-6.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部